(Q40649819)

22 September 2017

Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium (English)

1 reference

22 September 2017

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00068-2

30 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00068-2

30 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00068-2

30 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00068-2

30 December 2023

author name string

Janne Jensen

1

1 reference

22 September 2017

Per Briand

3

1 reference

22 September 2017

Fernand Labrie

4

1 reference

22 September 2017

Jason W. Kitlen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732292

30 December 2023

Anne E. Lykkesfeldt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732292

30 December 2023

language of work or name

1 reference

1 March 2003

1 reference

full work available at URL

22 September 2017

https://api.elsevier.com/content/article/PII:S0960076003000682?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00068-2

https://api.elsevier.com/content/article/PII:S0960076003000682?httpAccept=text/plain

30 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00068-2

The Journal of Steroid Biochemistry and Molecular Biology

30 December 2023

published in

1 reference

22 September 2017

84

1 reference

22 September 2017

4

1 reference

22 September 2017

469-478

1 reference

describes a project that uses

22 September 2017

MCF-7/S9

0 references

cites work

The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Tamoxifen in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

The value of estrogen and progesterone receptors in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Use of aromatase inhibitors in postmenopausal women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Fadrozole and letrozole in advanced breast cancer: clinical and biochemical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Recent advances in the clinical application of aromatase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Aromatase inhibitors in the treatment and prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

The effects of 17 beta estradiol and tamoxifen on the ZR-75-1 human breast cancer cell line in defined medium

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Extinction of insulin-like growth factor-I mitogenic signaling by antiestrogen-stimulated Fas-associated protein tyrosine phosphatase-1 in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Complete sequence of the cDNA for human .alpha.1-antitrypsin and the gene for the S variant

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Acquired antiestrogen resistance in MCF-7 human breast cancer sublines is not accomplished by altered expression of receptors in the ErbB-family.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Detection of aromatase and keratinocyte growth factor expression in breast tumors using reverse transcription-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182R-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Ligand-independent activation of steroid hormone receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900068-2

7 January 2021

Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen

3

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00068-2

Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration

30 December 2023

21

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00068-2

Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal

30 December 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00068-2

A potent specific pure antiestrogen with clinical potential

30 December 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00068-2

Prediction of relapse and survival in breast cancer patients by pS2 protein status

30 December 2023

36

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00068-2

The pS2/TFF1 trefoil factor, from basic research to clinical applications

30 December 2023

37

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00068-2

Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues

30 December 2023

56

1 reference

https://api.crossref.org/works/10.1016/S0960-0760(03)00068-2

30 December 2023

Identifiers

1 reference

22 September 2017

1 reference